Difference between revisions of "CCSP - 2021"

From MGH Learn Pathology
Line 33: Line 33:
 
<br>
 
<br>
 
{{ColorText|Tuesday, November 2, 2021|||3|}}<br>
 
{{ColorText|Tuesday, November 2, 2021|||3|}}<br>
* Indolent and Reactive Mimics of Lymphoma - Dr. Ferry
+
* [https://www.medialab.com/dv/dl.aspx?d=1749106&dh=fc1c3&u=111736&uh=c3cf8 Indolent and Reactive Mimics of Lymphoma - Dr. Ferry]
* Mucinous Tumors of the Ovary - Dr. Young
+
* [https://www.medialab.com/dv/dl.aspx?d=1749117&dh=d3b60&u=111736&uh=c3cf8 Mucinous Tumors of the Ovary - Dr. Young]
* Critical Values in Perinatal Pathology - Dr. Roberts
+
* [https://www.medialab.com/dv/dl.aspx?d=1749110&dh=3f205&u=111736&uh=c3cf8 Critical Values in Perinatal Pathology - Dr. Roberts]
* Diffuse Large B-Cell Lymphoma, An Update - Dr. Sohani
+
* [https://www.medialab.com/dv/dl.aspx?d=1749116&dh=083dc&u=111736&uh=c3cf8 Diffuse Large B-Cell Lymphoma, An Update - Dr. Sohani]
* Eight Common Reasons - Dr. Roberts
+
* [https://www.medialab.com/dv/dl.aspx?d=1749127&dh=876b6&u=111736&uh=c3cf8 Eight Common Reasons - Dr. Roberts]
* Testis - Dr. Cornjeo
+
* [https://www.medialab.com/dv/dl.aspx?d=1749111&dh=01116&u=111736&uh=c3cf8 Testis - Dr. Cornjeo]
* Selected Benign Bladder Lesions - Dr. Young
+
* [https://www.medialab.com/dv/dl.aspx?d=1749108&dh=3cacd&u=111736&uh=c3cf8 Selected Benign Bladder Lesions - Dr. Young]
* 2021 WHO Classification of CSN - Dr. Louis
+
* [https://www.medialab.com/dv/dl.aspx?d=1749109&dh=a1032&u=111736&uh=c3cf8 2021 WHO Classification of CSN - Dr. Louis]
* Premalignanv Malignant Epithelial Lesions - Dr. Watkins
+
* [https://www.medialab.com/dv/dl.aspx?d=1749113&dh=b0e6b&u=111736&uh=c3cf8 Premalignancy Malignant Epithelial Lesions - Dr. Watkins]
 
<br>
 
<br>
 
{{ColorText|Wednesday, November 3, 2021|||3|}}<br>
 
{{ColorText|Wednesday, November 3, 2021|||3|}}<br>

Revision as of 09:52, October 25, 2021

Case Presentations

All

Monday, November 1, 2021


Tuesday, November 2, 2021


Wednesday, November 3, 2021


Thursday, November 4, 2021


Friday, November 5, 2021

  • 12:30 pm – 1:15 pm: Gastrointestinal Pathology, Stuti G. Shroff
  • 1:15 pm – 2:00 pm: Genitourinary Pathology, Chin-Lee Wu


Monday, November 1, 2021


Tuesday, November 2, 2021


Wednesday, November 3, 2021

  • Challenges in Salivary Gland Pathology - Dr. Faquin
  • Gastrointestinal Polyps - Dr. Zukerberg
  • 2021 WHO Class of Lung Tumors - Dr. Mino-Kenudson
  • Diagnosis of Interstitial Lung Disease - Dr. Hairi
  • Vasculitis - Dr. Stone
  • Nipple Lesions - Dr. Ly
  • Fibroepithelial Neoplasms - Dr. Lerwill
  • Melanocytic Neoplasms - Dr. Foreman


Thursday, November 4, 2021

  • BD Challenges & Controversies - Dr. Misdraji
  • Papillary Lesions - Dr. Lerwill
  • Endocervical - Dr. Oliva
  • EBC-associated LPD - Dr. Sohani
  • Pleural Peritoneal Meso - Dr. Hung


Friday, November 5, 2021

  • Mesenchymal tumors - Dr. Oliva
  • IBD Challenges & Controversies - Dr. Misdraji
  • IBD Challenges & Controversies - Dr. Deshpande
  • Prostate Cancer Pathology - Dr. Wu
  • Approach to Mistakes - Dr. Heher
  • Gastritis Beyond H - Dr. Zukerberg
  • Germ Cell Tumors of the Ovary - Dr. Young